Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Citpressine I

    • Product Name Citpressine I
    • Alias Adrenaline
    • Einecs 241-318-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    875874

    product_name Citpressine I
    active_ingredient Argipressin
    drug_class Vasopressin analog
    form Injection
    concentration 20 IU/mL
    route_of_administration Intravenous
    manufacturer Aguettant
    indications Management of diabetes insipidus and bleeding esophageal varices
    storage_temperature 2°C to 8°C
    packaging Ampoule
    prescription_status Prescription only
    ATC_code H01BA01
    country_of_origin France

    As an accredited Citpressine I factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Citpressine I is packaged in a 10g amber glass vial, sealed with a red screw cap, featuring hazard and handling labels.
    Shipping Citpressine I should be shipped according to standard protocols for chemical substances. Ensure the container is tightly sealed, labeled, and cushioned to prevent breakage during transit. Protect from extreme temperatures and moisture. Follow all relevant regulations for hazardous materials, and include safety data sheets with the shipment for proper handling and emergency response.
    Storage Citpressine I should be stored in a cool, dry, and well-ventilated area, away from direct sunlight, heat sources, and incompatible materials such as strong oxidizers. Keep the container tightly sealed to prevent moisture ingress. Store at recommended temperatures (often 2–8°C unless otherwise specified) and ensure proper labeling. Follow all relevant safety and regulatory guidelines during storage.
    Application of Citpressine I

    Applications of Citpressine I in Industrial Manufacturing

    As the direct manufacturer of Citpressine I, we ensure its strict quality and performance characteristics for precisely defined downstream industrial applications. Below we detail key sector-specific scenarios where Citpressine I demonstrates measurable value, with a focus on adherence to regulatory requirements, dosing guidance, process integration, and finished goods outcomes.

    1. Hemostatic Pharmaceuticals Manufacturing

    Citpressine I serves as an active pharmaceutical ingredient in the production of specialized hemostatic injectables and topical preparations for hospital and surgical applications. Downstream formulators value its strong vasoconstrictive properties, which maintain predictable clinical performance. Integration takes place under regulated cleanroom production, with tight batch-to-batch assay control.

    Industry compliance standards

    • Ph. Eur. (European Pharmacopoeia) monographs for hemostatic agents
    • USP (United States Pharmacopeia) guidelines for injectable pharmaceuticals
    • China Pharmacopoeia (ChP) standards for blood products
    • WHO Good Manufacturing Practice (GMP) for APIs and finished dosage forms

    Typical usage ratio

    • 0.002 – 0.025% w/v, adjusted based on required vasoconstrictive effect for injectable or topical pharmaceutical products

    Downstream process integration

    • Charged during active ingredient blending phase; dissolved fully in WFI (Water for Injection) prior to sterile filtration; subjected to final sterile filling and freeze-drying depending on product form

    Final product types

    • Hemostatic injection ampoules for operating theaters
    • Sterile hemostatic gels and sprays for emergency medicine
    • Combination wound dressings containing vasoconstrictors

    2. Veterinary Injectable Solution Production

    Citpressine I finds targeted use in veterinary medicine as a critical component of injectable agents given during surgical procedures on livestock and companion animals to minimize blood loss. Veterinary pharma manufacturers rely on its stability and defined action to meet both clinical and regulatory standards for animal treatment formulations.

    Industry compliance standards

    • VICH GL9 Good Manufacturing Practices for veterinary APIs
    • European Medicines Agency (EMA) veterinary product requirements
    • US FDA Center for Veterinary Medicine (CVM) guidelines
    • ISO 9001:2015 quality management for veterinary pharmaceuticals

    Typical usage ratio

    • 0.003 – 0.011% w/v, adjusted to animal body mass and procedure-specific requirements

    Downstream process integration

    • Incorporated at the active compound preparation stage, followed by filtration, sterile formulation, and custom vial or pre-loaded syringe packaging for veterinary clinics

    Final product types

    • Veterinary hemostatic solution vials for small and large animals
    • Pre-mixed surgical kits for livestock procedures
    • Emergency injectables for veterinary operating rooms

    3. Dental Surgery Hemostasis Cartridge Manufacturing

    The dental sector applies Citpressine I in the formulation of local hemostatic cartridges and pads employed during oral surgeries and periodontal interventions. Producers in this segment must comply with medical-grade excipient standards and establish traceability in batch formulation for single-use and procedural dental products targeting intraoperative bleeding control.

    Industry compliance standards

    • European Medical Device Regulation (MDR) for dental consumables
    • ANSI/ADA Specifications No. 27 for dental cartridge solutions
    • ISO 13485:2016 for dental device quality management
    • FDA 21 CFR Part 872, Subpart D requirements for dental products

    Typical usage ratio

    • 0.01 – 0.035% w/v, titrated for each dental cartridge or absorbent pad based on the targeted hemostatic effect and pad thickness

    Downstream process integration

    • Dispensed in sterile form for solution-impregnation of absorbent pads or direct filling into pre-sterilized dental cartridge shells, followed by terminal sterilization and sealed packaging

    Final product types

    • Single-use dental hemostatic solution cartridges
    • Hemostatic-impregnated absorbent dental pads
    • Surgical mouth packs for oral and maxillofacial procedures

    4. Advanced Hemostatic Wound Dressing Manufacture

    Citpressine I acts as a functional additive in the production of advanced wound dressings where rapid local vasoconstriction is clinically important. Medical textiles companies integrate the compound in controlled-release wound care matrices, with strict adherence to biocompatibility and controlled dosing for various trauma and postoperative care kits.

    Industry compliance standards

    • ISO 10993 biocompatibility evaluation for medical devices
    • EN 13795-1 requirements for wound dressing materials
    • FDA 21 CFR Part 820 Quality System Regulation
    • CE Marking for Class IIb medical textiles

    Typical usage ratio

    • 0.005 – 0.022% w/w, defined during matrix casting or impregnation; ratio depends on intended release kinetics and dressing layer thickness

    Downstream process integration

    • Blended into hydrogel or nonwoven matrix precursor solution, followed by casting or impregnation onto fabric backing, then drying, sterile irradiation, and individually sealed packaging

    Final product types

    • Sterile trauma wound dressings with rapid hemostasis
    • Postoperative absorbent pads with controlled vasoconstriction
    • Home-care wound kits for minor and moderate bleeding events

    5. Integrated Hemostatic Foam Systems for Emergency Response

    Emergency medical device manufacturers embed Citpressine I into expanding foam technologies designed for rapid bleeding control in pre-hospital trauma care and military field medics. Formulation and process controls ensure precise dosage and uniform dispersion within foam matrices, critical for fast deployment in uncontrolled environments.

    Industry compliance standards

    • ISO 13485:2016 for emergency medical systems manufacturing
    • EN 556-1: Sterilization of medical devices
    • FDA 21 CFR Part 878 General and Plastic Surgery Devices
    • Relevant national EMT equipment standards

    Typical usage ratio

    • 0.007 – 0.016% w/w, calculated against total foam matrix mass to achieve target therapeutic levels at wound contact surface

    Downstream process integration

    • Homogenized within polyurethane foam precursor prior to rapid expansion; system injected into wound simulant molds, then subjected to thermal stabilization, surface finish treatment, and gamma sterilization

    Final product types

    • Pre-loaded emergency hemostatic foam canisters
    • Trauma foam dressings for military field medics
    • Rapid-application foam kits for ambulance and ER response units
    Free Quote

    Competitive Citpressine I prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Citpressine I: Consistency Rooted in Manufacturing Experience

    Practical Chemistry on the Production Floor

    We introduce Citpressine I from a hands-on view most laboratories and production lines can recognize. Years spent refining this product have left us less interested in buzzwords and more focused on what actually makes the difference for users. Citpressine I grew out of practical problems observed at scale, not out of a formula conjured in a boardroom. Every pound produced gets tested against conditions that match your reality, not desk-bound test runs. We don’t build batches around convenience for us. Instead, we work for uniformity that users can trust, because nothing derails a shift faster than inconsistent product behavior.

    How Citpressine I Sets Itself Apart from the Crowd

    Most chemical suppliers offer variations on old standards, sometimes chasing novelty that doesn’t solve real problems. Citpressine I started with a different question: Where do customers really lose time in processing? What slows down throughput or complicates blending? We learned from countless conversations, troubleshooting calls, and plant trials. Consistency in particle size and flow seem to separate the reliable suppliers from those who just fill containers. We took that lesson to heart in formulation and manufacturing, adjusting milling and screening lines, monitoring every batch by skilled operators—not machines alone.

    Citpressine I is more than just a chemical blend. It’s a guarantee that operators can feed, meter, and blend confidently. Anyone running an automated tabletting press knows the headache that comes from powders sticking, clumping, or bridging in the chute. Hours we spent addressing these issues for our clients found their solution in a product that flows and packs the same every run—so machines can do what they’re supposed to do without the oversight that costs time and labor.

    Specifications Made for Reality

    Many industries rely on spec sheets, but seasoned users know specs only tell part of the story. For Citpressine I, lab values reflect what operators see: practical bulk density, stable moisture content, and controlled content uniformity within tight tolerances. These features don’t just look tidy on a certificate of analysis; they translate into fewer batch corrections on production day. We routinely run comparison checks against competitor samples, especially when a partner reports inconsistent behavior from lesser products. Each time, Citpressine I delivers on reproducibility—run after run, shift after shift.

    We keep the focus on simple, clear results. The typical lot of Citpressine I maintains free-flowing characteristics in high humidity as well as under drier conditions. Our process design team built humidity controls directly into the storage and packaging lines, reducing the guesswork and the rejections that waste material and labor. We found this approach eliminates the need for excess in-line drying or secondary adjustments. Our team will show you real-world results that other producers struggle to guarantee, no matter where their plant sits.

    Model Specificity: No Throwaway Formulations

    Many so-called “all-purpose” blends only serve to muddy performance for advanced users. With Citpressine I, we didn’t chase that market. Instead, we deliver a model that responds to the daily grind of high-throughput production. Our approach avoided catch-all ingredient lists that complicate both compliance and troubleshooting. Each excipient and carrier in Citpressine I was selected for compatibility, ease of handling, and proven performance under variable plant conditions. Strict monitoring and continuous feedback cycles led us to refine the base blend, so even tiny deviations get caught long before shipment. This gives our clients confidence to scale without risking downstream variation.

    There’s nothing generic about how Citpressine I interacts with active ingredients. We base the model on hundreds of documented batch records, not only laboratory trials but production-scale runs—so formulators avoid unpleasant surprises when scaling up. In settings where a half-percentage point can turn success into rework, Citpressine I delivers repeatability in both physical and chemical dimensions. The production crew notices less cleanup, smoother flow, and less dust at pack-off, all because real-life input drove our process choices.

    Usage by Professionals, Not Theorists

    Citpressine I found the most loyal following among those who can’t interrupt an operation to re-blend or re-feed material. It’s chosen in compaction, direct compression, and wet granulation processes where reliability and reduction in off-spec waste matter. Some users handle millions of tablets a week, and others process bulk intermediates for contract manufacturing. Across the board, feedback circles back to predictability: the powder doesn’t cake, bridging gets minimized, and metering equipment works as designed. Preventing process stoppages means more than just convenience; it’s about meeting delivery deadlines and keeping contracts.

    Operators also note that Citpressine I runs clean, with less residue left on mechanical parts. Equipment maintenance cycles stretch longer when abrasive fillers or poorly milled ingredients aren’t present. Many customers prefer it for active ingredient formulations that are sensitive to shear or heat, since the blend resists degradation during energetic mixing. Some lines run at full tilt for months, seeing thousands of cycles without the need for re-calibration at the feeder. It is not just the lab manager but also the machine operator whose workday gets easier because of the small details built into this product.

    Transparent Process, No Surprises

    Certain blends from other suppliers show noticeable lot-to-lot drift, which often goes unnoticed until a full run gets disrupted or yields drop. We designed Citpressine I to avoid this pitfall by replacing batchwise “artistry” with rigorous but practical process controls developed and refined by veteran mixers and machine operators. Direct communication between our process engineers and plant staff means problems get solved before they travel downstream to the customer.

    We do not rely entirely on automated systems to catch defects. Manual verification by trained workers, who understand the quirks of each production line and the realities of bulk transport, adds a defensive layer machines alone cannot provide. Far from “slowing down” the process, this hands-on oversight keeps customer complaints low and reliability high. The process may look simple, but every step comes from lessons learned addressing issues nobody put in a textbook.

    Comparing Citpressine I with Industry Standards

    Other comparable blends face challenges keeping moisture consistent, achieving reproducible particle sizing, or surviving long-haul logistics. We have run side-by-side trials at facilities that faced chronic jamming with competing products. In these settings, Citpressine I helped cut maintenance hours, lowered dust counts for operators, and provided the reliable flow needed to automate dosing and filling lines. This translates into more uptime for high-value equipment and reduced risk of contamination.

    Citpressine I also resists segregation during storage and handling, sustaining the intended content through shipping and warehouse turns. Some alternative products break down or lump up before they reach the floor, leaving users to chase the cause of uneven blends. Our blend stands up to pneumatic transfer, auger feeds, and even hand tipping without visible or functional separation. Every improvement we introduce traces back to experiences reported by operators, not abstract ideals on a whiteboard.

    Downstream Solutions: Making Real Work Easier

    Plant managers working with Citpressine I often talk about the reduction in handwork, technical interventions, and waste. No engineer wants to spend the afternoon chasing the reason for feeder clogs or sifting batches due to unexpected lumps. A product that supports a cleaner workflow really does add to bottom-line efficiency. In our own facility, changes introduced with Citpressine I led to measurable drops in rejection rates and post-production corrections. This forms the core of our value—not a fanciful lab result outlined in a presentation, but tangible improvements to daily operations.

    We learn most from hands-on feedback, which sometimes prompts us to tweak our own process or even re-run trial batches for quality improvement. The product continues to evolve where it matters, not just with tweaks for marketing claims. Where customers notice specific improvement opportunities, such as reducing fines or optimizing for a unique environment, we turn around pilot lots and collect performance data rapidly. The feedback loop stays alive so that evolution matches real production pressures.

    Transparency and Traceability: What Our Customers See

    Real scrutiny in chemical manufacturing comes not from regulator visits alone, but from what users find on their line. Traceability with Citpressine I means each lot connects back to specific feedstocks, controlled storage conditions, and reviewable records stretching from receipt to delivery. We build traceability without complicating logistics or bogging down operators. Customers often ask to tour our plant, and we welcome the visits because our process stands up to real-world inspection—right down to the daily cleaning logs. This openness creates trust that a digital spec sheet cannot replace.

    Certification efforts are only meaningful when supported by a culture that cares about visible, repeatable quality. Plant tours, batch reviews, and independent tests play a major role in our customer relationships. We don’t hide behind jargon or refuse to answer hard questions—if there’s a legitimate concern, our production and quality managers handle it directly. This builds respect with partners who stake their business success on our consistency.

    Lifecycle Value That Shows Up in Real Results

    Over the years, it’s become clear that the longer a customer works with Citpressine I, the less they need to interact with troubleshooting or make after-the-fact adjustments. Many cite improvements not just at the tabletting press or mixer, but further downstream in packaging and QC. Because the blend stays stable in storage and shipment, product deviation reports drop significantly. Several clients share post-implementation data pointing to reductions in batch failures, lower labor costs due to less frequent cleaning, and improved regulatory compliance rates. These improvements build slowly, but over the lifecycle of multi-year partnerships, they make a substantial difference to anyone charged with maintaining margins.

    As volumes grow and processes get more automated, any inconsistency will be revealed—inevitably costing money and sometimes reputation. We respond with small but vital actions: faster root cause analysis, real-time adjustments, or even on-site presence during system integration. Citpressine I’s reliability stems from a quiet backbone of incremental improvements, not sweeping re-engineering with each cycle. This method supports longevity for both product and relationship.

    Listening to Real-World Requirements, Not Marketing Slogans

    Each new market segment comes with distinct challenges, but one factor remains constant—nobody has time for unreliable batch materials. That lesson comes straight from the shop floor to the R&D lab. Our technical staff keeps direct lines of communication open with plant managers, not just sales channels. When someone on the floor flags a new issue, the team responds with focused troubleshooting and direct feedback sessions. In one case, a customer running a new process flagged a minor sticking problem, prompting our production team to refine the product’s moisture profile in the very next lot. It’s this kind of responsiveness that lets Citpressine I support lines running specialty actives, not just generic runs.

    Feedback isn’t filtered through layers of management. The same operators who blend, dry, and package Citpressine I handle customer queries, so the advice you receive reflects direct knowledge, not a script. Many adjustments over the years—small tweaks in ingredient sourcing, improvements in drying times, adjustments to screening mesh—came directly from customer partnership. We’re not inflexible about our process, because manufacturing challenges rarely stand still. We stay ready to match the scale and demands of those who depend on us daily.

    Solving Site-Specific Challenges with Experience

    Every facility has its quirks: variation in HVAC, the way conveyors operate, even small but important calibration differences between dosing systems. We’ve walked the production floor with customers from contract manufacturers to fully integrated pharmaceutical plants and chemical producers. Citpressine I’s formulation keeps surprises rare, no matter the quirks encountered. If an issue arises, our technical staff don’t just send a revised batch—they dig in with root-cause analysis based on years of hands-on troubleshooting. Fast fixes do not substitute for sustainable solutions, so both immediate answers and long-term adjustments shape how Citpressine I adapts to changing requirements.

    Case histories from users reflect savings not just in raw material, but in reduced labor turnover—operators prefer to stick with lines that don’t complicate their day. Our approach to product development includes classroom and on-the-floor training whenever a customer transitions or scales up. Knowledge transfer becomes an integral part of a new adoption, so customers grow comfortable and confident with every step from intake through packaging. By investing time up front, we reduce downtime, eliminate unnecessary consultancy, and let technical staff build trust.

    Citpressine I’s Contribution to Greater Process Control

    Process control improves only when batch material supports automation and consistency at every handoff. The detailed work we’ve done on Citpressine I reduces problems seen at the feed hopper and the finished product stage. The goal extends beyond quick wins; we pursue a steady rise in line uptime, lower need for stoppages, and the ability to chase leaner margins without risk. Labs and QA teams confirm the stable chemical profile on repeated sampling, with reduced variance in downstream quality metrics. This simple, predictable performance ends the cycle of adjusting machine settings for each lot, saving both time and operating costs.

    Operators from various industries point to the reduced training curve and troubleshooting frequency as lasting value. The consistent nature of Citpressine I allows new staff to learn quickly and seasoned operators to focus on higher-value tasks rather than micromanaging inconsistencies. The savings accrue quietly, but the difference becomes obvious to anyone who has worked both with and without this level of material consistency.

    Reflecting on a Decade of Uninterrupted Supply

    Behind every success story with Citpressine I, you’ll find months and even years of supply without interruption—no last-minute substitutions, no emergency reformulations, no unexplained discrepancies. As a manufacturer, we measure success by customer longevity and repeat engagement, not a spike in quarterly sales. Customers appreciate this steadiness, especially those who work in regulated markets where paperwork and compliance headaches multiply when materials fluctuate.

    We draw on detailed records to support compliance audits, batch recalls, or customer reviews. Instead of retrofitting documentation after the fact, our practices anticipate the rigorous scrutiny appropriate for pharmaceutical, nutraceutical, and specialty chemical production. Every adjustment, whether minor or major, is logged and available for full transparency. This level of documentation comes from direct experience answering tough regulatory questions, and from living through the disruptive impact of unreliable suppliers.

    Building Value with Every Batch

    Our outlook remains grounded: each batch of Citpressine I reflects hundreds of adjustments born from customer feedback, operator experience, and the realities of long-term manufacturing. We keep the lines open for improvement and invite scrutiny because we know every advantage in material handling and process consistency leads directly to real-world savings. Customers who switch to Citpressine I often remark they wish they’d made the change sooner—sometimes saving not just in dollars but in day-to-day aggravation that no spreadsheet can measure.

    The difference with Citpressine I runs deeper than what can be captured in a spec sheet. It’s built into the process, the operator confidence, and the unplanned positives that show up once materials start working for you instead of against you. Our role as manufacturer pulls us back to the day-in, day-out details—answering questions, adapting to new needs, and never losing sight of the practical value each run provides to the people and machines depending on us.